Improving Care and Reducing Cost Study

Summary

The goal of the Improving Care and Reducing Cost (ICRC) Program, is to improve disease management and the overall process of care in treating the chronic illness schizophrenia in order to reduce ER visits and hospital days while providing better care, better health and increased patient satisfaction. This will be done by fostering innovation in the use of technology and by training and deploying a new cadre of personnel in the behavioral health field: Mental Health/Health Technology (MH/HT) Case Managers.

Conditions

• Schizophrenia
• Schizoaffective Disorder
• Psychosis NOS

Interventions

BEHAVIORAL

Relapse Prevention Plan

brief, in-person, relapse prevention counseling with supplemental web-based learning modules,

BEHAVIORAL

Daily Support Website

web-based program for patients and families that provides psychoeducation about schizophrenia and its treatments to improve knowledge, increase problem-solving skills and offer social support through the use of web-based therapist facilitated sessions

BEHAVIORAL

Computer CBT for voices and paranoia

A ten-session CBT programs, one to address voices and the other for paranoia. The web-based programs incorporate the essential elements of CBT for psychosis such as normalizing behavior and offering behavioral coping strategies

BEHAVIORAL

FOCUS

an interactive smart phone text-messaging application to support medication adherence, facilitate coping with symptoms and improve daily functioning in individuals with schizophrenia

OTHER

Prescriber Decision Assistant

is a web-based prescriber decision support system that includes a brief patient-completed assessment describing symptoms and adverse events which prompts the prescriber to conduct a detailed clinical assessment. Embedded in the program are decision supports for medication choices based on best evidence-based practices regarding symptoms, side effects, information from laboratory tests and history of prior treatment response

Sponsors & Collaborators

• University of Pittsburgh

  collaborator OTHER

• Boston University

  collaborator OTHER

• Dartmouth-Hitchcock Medical Center

  collaborator OTHER

• Northwell Health

  lead OTHER

Principal Investigators

• John Kane · Northwell Health

Study Design

Allocation

NA

Purpose

TREATMENT

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Max Age

60 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2013-04-30

Primary Completion

2015-06-30

Completion

2015-06-30

Countries

• United States

Study Locations